11.06.13
Carlos Picosse has been appointed chief executive officer and Dr. Renato Lobo has been named chief medical officer of iBio Brazil, a subsidiary the company is forming to manage and expand business activities in the country. Mr. Picosse is the former group president of Valeant Farmaceutica do Brasil Ltda, and Dr. Lobo is the former medical and regulatory director of Valeant Farmaceutica do Brasil Ltda.
Additionally, iBio has sold one million shares of its common stock to Mr. Picosse and 200,000 shares to Dr. Lobo for a total consideration of $480,000.
Additionally, iBio has sold one million shares of its common stock to Mr. Picosse and 200,000 shares to Dr. Lobo for a total consideration of $480,000.